Novocure Ltd
NASDAQ:NVCR
Novocure Ltd
NASDAQ:NVCR
Price:
11.66
USD
-4.03%
Market Cap:
$1.3B
Relative Value
The Relative Value of one
NVCR
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 11.66 USD,
Novocure Ltd
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
NVCR Relative Value
HIDDEN
Multiples Across Competitors
NVCR Competitors Multiples
Novocure Ltd Competitors
Novocure Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| JE |
|
Novocure Ltd
NASDAQ:NVCR
|
1.3B USD | 2 | -9.6 | -7.8 | -7.1 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
184.1B USD | 4.1 | 28.1 | 16.1 | 22.1 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
170.1B USD | 16.9 | 59.4 | 45.1 | 55.4 | |
| US |
|
Stryker Corp
NYSE:SYK
|
129B USD | 5.1 | 39.7 | 20.3 | 24.5 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
111.3B USD | 3.1 | 24 | 13.3 | 19.3 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
103.7B USD | 5.1 | 35.6 | 20.9 | 28.1 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
47.9B USD | 7.9 | 44.4 | 24.4 | 26.8 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
41.4B EUR | 1.8 | 19.6 | 11 | 15.5 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
46B USD | 10.7 | 43.4 | 30.8 | 34.1 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
44.4B USD | 2 | 25 | 9.9 | 16.7 | |
| US |
|
Resmed Inc
NYSE:RMD
|
32.9B USD | 6.1 | 22.2 | 15.6 | 17.3 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
